TLDR
- BofA Securities maintained its Buy rating on IBM alongside a $340 price objective after conducting a call with CEO Arvind Krishna
- Krishna emphasized that AI agents will accelerate expansion in systems of record, spanning databases and software infrastructure
- IBM exceeded Q4 EPS projections, delivering $4.52 versus the anticipated $4.33, while revenue climbed 12.2% year-over-year to $19.69 billion
- IBM introduced watsonx-powered fan experiences for the 90th Masters Tournament, demonstrating its agentic AI potential
- Institutional ownership stands at 58.96%, with Vanguard maintaining 95.8 million shares as the top institutional stakeholder
BofA Securities has maintained its Buy rating on IBM while preserving its $340 price objective following a CEO conversation with Arvind Krishna conducted by analyst Wamsi Mohan through the firm’s “View from the Top” series.
International Business Machines Corporation, IBM
Krishna utilized the conversation to outline IBM’s strategic approach to agentic AI. His central thesis: AI agents require expanded infrastructure access, positioning systems of record such as databases and related software components for accelerated growth.
He emphasized that demonstrable return on investment evidence during the upcoming two years will prove essential for sustaining capital expenditure on AI infrastructure. This represents a pragmatic perspective that establishes IBM’s credible position in the AI landscape.
Regarding strategic partnerships, IBM revealed a five-year alliance with Lam Research to investigate novel materials and methodologies for sub-1nm logic scaling. The initiative will concentrate on high-NA EUV lithography, aiming to advance IBM’s logic scaling timeline.
IBM Demonstrates AI Capabilities at The Masters
IBM incorporated a prominent showcase into its AI portfolio by introducing new watsonx-powered experiences for the 90th Masters Tournament. The platform delivers conversational archives alongside real-time hole insights, providing golf enthusiasts with an interactive AI-enhanced experience during one of sport’s premier events.
Several financial outlets observed IBM surpassing the broader market on the day the Masters deployment received coverage, with analysts identifying the AI demonstration as a driver for investor interest.
IBM stock began trading at $248.38 on Tuesday. The one-year trading range extends between $214.50 and $324.90. The shares are presently positioned below both the 50-day moving average of $270.58 and the 200-day moving average of $285.09.
The market capitalization reaches $232.98 billion, accompanied by a PE ratio of 22.28 and a beta of 0.73.
Quarterly Earnings Performance and Dividend Distribution
IBM’s latest quarterly earnings, disclosed January 28th, registered $4.52 EPS, surpassing the $4.33 analyst projection by $0.19. Quarterly revenue reached $19.69 billion, exceeding the $19.23 billion forecast and representing a 12.2% year-over-year increase.
Net margin registered at 15.69% while return on equity measured 38.15%. Analysts project full-year EPS of $10.78.
IBM distributed a quarterly dividend of $1.68 per share on March 10th, establishing an annualized yield of 2.7%. The payout ratio presently stands at 60.27%.
Regarding institutional holdings, Vanguard maintains 95.8 million shares, State Street holds 54.5 million, and Capital World Investors expanded its position by 13.9% in Q3 to 17 million shares. Total institutional ownership comprises 58.96%.
Triumph Capital Management reduced its stake by 78.4% in Q3, divesting 3,777 shares and retaining only 1,039 shares valued at $293,000.
Insider transactions have been limited yet notable. Director David Farr acquired 1,000 shares at $304.00 on January 30th. Director Michael Miebach purchased 434 shares at $233.33 on February 25th. During the past three months, insiders have acquired 1,484 shares totaling $417,157.
The consensus Wall Street rating on IBM stands at “Moderate Buy” with an average price target of $314.60. Among analysts following the stock, eleven maintain a Buy rating, one holds a Strong Buy, and eight carry Hold ratings.
Oppenheimer maintains the highest target at $380.00, while Stifel elevated its target from $325.00 to $340.00 in late January.
